Status:
COMPLETED
Research Report: CERITER Clinical Study - Stride One
Lead Sponsor:
Ceriter Nederland BV
Collaborating Sponsors:
FRAME Jessa Ziekenhuis, Belgium
Conditions:
CVA (Cerebrovascular Accident)
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this clinical study is to investigate the short-term impact of the use of Ceriter Stride One on the quality of gait in patients rehabilitating after a cerebrovascular accident (CVA). Strid...
Detailed Description
Both therapist and patient reported an improvement in the quality of the foot roll-off pattern in 100% of cases. This improvement was also objectively determined in the data measured by Stride One, wi...
Eligibility Criteria
Inclusion
- CVA, residentially admitted to the rehabilitation center in Herk-de-Stad, Belgium
- Older than 18 years of age
- Gait problems as a result of the CVA
- Able to walk safely and independently (possibly with a walking aid)
- Able to understand and sign an information and consent form
Exclusion
- Severe cognitive problems (attention) that make it difficult to understand instructions or follow feedback
- Hearing problem
Key Trial Info
Start Date :
December 18 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 29 2024
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT06560450
Start Date
December 18 2023
End Date
April 29 2024
Last Update
August 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Frame, Jessa Ziekenhuis
Hasselt, Belgium, 3500